DUBLIN--(BUSINESS WIRE) — Research and Markets (https://www.researchandmarkets.com/research/j6gdbh/dental_pain_global) has announced the addition of GlobalData’s new report “Dental Pain Global Clinical Trials Review, H1, 2012” to its offering.
GlobalData's clinical trial report, “Dental Pain Global Clinical Trials Review, H1, 2012” provides data on the Dental Pain clinical trial scenario. The report provides elemental information and data relating to the clinical trials on Dental Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.
The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dental Pain. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
The scope of the report includes:
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
The report is aimed at providing an understanding of the dynamics of a particular indication in a condensed manner and an abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type, and many more.
For more information visit https://www.researchandmarkets.com/research/j6gdbh/dental_pain_global